Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pluri Inc. Director's Dealing 2021

Jan 6, 2021

6990_dirs_2021-01-06_e4205d09-bc09-48d1-8163-7dac1db5b452.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2021-01-05

Reporting Person: Shemesh-Rasmussen Maital (Director)

More from Pluri Inc.

Regulatory Filings 2026
Jun 2
Report Publication Announcement 2026
Jun 2
Report Publication Announcement 2026
Jun 1
Capital/Financing Update 2026
Jun 1
Capital/Financing Update 2026
Jun 1
Report Publication Announcement 2026
May 14
Interim / Quarterly Report 2026
May 14
Interim / Quarterly Report 2026
May 14
Annual Report 2026
Apr 23
Report Publication Announcement 2026
Apr 23
View all filings →